Anti-angiogenesis: a new concept in therapy of solid malignancies?
Schweigerer, L.
Medizinische Klinik 90(12): 709-712
1995
ISSN/ISBN: 0723-5003 PMID: 8583988 Document Number: 449002
Document emailed within 1 workday
Related Documents
Usui, N. 2019: Hematologic Malignancies/Pediatric Malignancies Current Guidelines of Clinical Management and Drug Therapy for Hematological Malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(5): 859-861Chelariu-Raicu, A.; Coleman, R.L.; Sood, A.K. 2019: Anti-Angiogenesis Therapy in Ovarian Cancer: which Patient is it Most Likely to Benefit? Oncology 33(7)
McKinnon, C. 1999: Prostate cancer, biological therapy, signal transduction inhibitors and anti-angiogenesis agents Idrugs: the Investigational Drugs Journal 2(7): 624-628
Kosch, M.; Könecke, J.; Hausberg, M.; Kisters, K. 2001: Incidence of de novo malignancies in renal transplant patients after anti-T-lymphocytic therapy Clinical Nephrology 56(6): S35-S36
Hirai, F. 2015: III. Role of Anti-Angiogenesis Therapy for Advanced Non-Small Cell Lung Cancer - Current Status and Future Challenges Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(8): 940-943
Giles, F.J. 2002: The emerging role of angiogenesis inhibitors in hematologic malignancies Oncology 16(5 Suppl 4: 23-29
Rosen, L.S. 2001: Angiogenesis inhibition in solid tumors Cancer Journal 7(Suppl 3): S120-S128
Saphir, A. 1997: Angiogenesis: the unifying concept in cancer? Journal of the National Cancer Institute 89(22): 1658-1659
Krzystek-Korpacka, M.; Matusiewicz, M.; Diakowska, D.; Grabowski, K.; Neubauer, K.; Kustrzeba-Wojcicka, I.; Terlecki, G.; Gamian, A. 2008: Respiratory insufficiency related to COPD accelerates systemic inflammation, under-nutrition, and angiogenesis in esophageal malignancies Experimental Oncology 30(1): 75-80
Robbins, B.A.; de la Vega, D.; Ogata, K.; Tan, E.M.; Nakamura, R.M. 1987: Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies Archives of Pathology and Laboratory Medicine 111(9): 841-845
Werther, K.; Nielsen, H.J. 2000: Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors Ugeskrift for Laeger 162(37): 4916-4920
Mariani, S.M. 2003: Anti-angiogenesis: the challenges ahead Medgenmed: Medscape General Medicine 5(2): 22
Takano, S.; Matsumura, A. 2006: Anti-angiogenesis treatment for brain tumors: present and future No Shinkei Geka. Neurological Surgery 34(7): 657-678
Sampi, K. 1987: Cancer chemotherapy combined with a calcium antagonist in patients with hematologic malignancies and solid tumors resistant to standard chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(3 Part 2): 951-955
Rajabi, M.; Adeyeye, M.; Mousa, S.A. 2019: Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer Current Medicinal Chemistry 26(30): 5664-5683
Perosa, F.; Scudeletti, M.; Imro, M.A.; Dammacco, F.; Luccarelli, G.; Indiveri, F. 1997: Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases Clinical and Experimental Rheumatology 15(2): 201-210
Guillaume, T.; Sekhavat, M.; Rubinstein, D.B.; Hamdan, O.; Leblanc, P.; Symann, M.L. 1994: Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution Cancer Research 54(14): 3800-3807
Qing, Z.J.; Ming, Q.X.; Zhong, T.F. 1997: Clinical evaluation of anti-tumor effects of Lentinan combined with chemotherapy in the treatment of various malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(Suppl 1): 1-8
Xiao, Y.-s.; Zhou, J.; Tang, Z.-y.; Fan, J.; Wu, Z.-q.; Liu, Y.-k.; Ye, S.-l.; Shen, Z.-z.; Xue, Q.; Zhao, Y. 2005: Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft Zhonghua Yi Xue Za Zhi 85(45): 3205-3209
Thomas, G. 1993: The concept of anti-oncogenes Pathologie-Biologie 41(1): 12